United States Patent (19) 11 4,206,215 Bailey 45 Jun
Total Page:16
File Type:pdf, Size:1020Kb
United States Patent (19) 11 4,206,215 Bailey 45 Jun. 3, 1980 54 ANTIMICROBIAL (56) References Cited BIS-4-(SUBSTITUTED-AMINO)-1- U.S. PATENT DOCUMENTS PYRIDINIUMALKANES 3,055,902 9/1962 Walker ............................ 260/296 D 75 Inventor: Denis M. Bailey, East Greenbush, 3,786,058 1/1974 Edwards ....................... 260/294.8 R N.Y. 73 Assignee: Sterling Drug Inc., New York, N.Y. OTHER PUBLICATIONS Walker et al., J. Org. Chem., vol. 26, pp. 2740-2747, 21 Appl. No.: 876,031 (1961). 22 Filed: Feb. 8, 1978 Austin, J. Pharm. Pharmacol., vol. 11, pp. 80-93, (1959). Primary Examiner-John D. Randolph Related U.S. Application Data Attorney, Agent, or Firm-Paul E. Dupont; B. Woodrow 63 Continuation-in-part of Ser. No. 721,315, Sep. 7, 1976, Wyatt abandoned, which is a continuation-in-part of Ser. No. 661,101, Feb. 25, 1976, abandoned. 57 ABSTRACT 30 Foreign Application Priority Data Bis-4-(R-amino)-1-pyridiniumalkanes are prepared by Feb. 11, 1977 (GB United Kingdom ................. 5784/77 reacting a 4-(R-amino)pyridine with an appropriate 51 Int. Cl. ..................... C07D 213/02; A61R 31/44 disubstituted alkane. The compounds are useful as anti 52 U.S. C. .................................... 424/263; 546/261; microbial agents. Certain species are also useful as den 546/264; 252/106 tal plaque-preventive agents. 58 Field of Search ................... 260/296 D; 252/106; 424/263; 546/261,264 45 Claims, No Drawings 4,206,215 1. 2 groups are linked through an alkylene group ANTIMICROBIAL bonded to the nitrogen atoms of the pyridine rings. BIS-(4-(SUBSTITUTED-AMINO)-1-PYRIDINIUM ALKANES SUMMARY OF THE INVENTION In a composition aspect, this invention relates to a CROSS-REFERENCE TO RELATED group of bis-(4-(R-amino)-1-pyridiniumlalkanes which APPLICATION are useful as antimicrobial agents. Certain of the com This application is a continuation-in-part of prior pounds are also useful as dental plaque-preventive copending application Ser. No. 721,315, filed Sept. 7 agents. 1976, now abandoned, in turn a continuation-in-part of 1 O In a further composition aspect the present invention application Ser. No. 661,101, filed Feb. 25, 1976 and provides an antimicrobial composition suitable for topi cal administration comprising an effective amount of a now abandoned. bis-(4-(R-amino)-1-pyridiniumlalkane and a compatible, pharmaceutically acceptable carrier. BACKGROUND OF THE INVENTION 15 1. Field of the Invention In another composition aspect, this invention relates The present invention relates to compositions of mat to a skin-cleansing composition comprising an antimi ter classified in the art of chemistry as bis-(4-(R-amino)- crobially effective amount of a bis-(4-(R-amino)-1- 1-pyridiniumalkanes, to a process for the preparation pyridinium-alkane, a compatible, pharmaceutically acceptable surfactant and a compatible, pharmaceuti thereof, to compositions containing these compounds 20 and to methods of using the same for controlling micro cally acceptable carrier. organisms and for preventing the formation of dental In yet another composition aspect, this invention plaque. provides an oral hygiene composition for the preven 2. Prior Art tion of dental plaque comprising an effective amount of Walker U.S. Pat. No. 3,055,902, issued Sept. 25, 1962 25 a dental plaque-preventive bis-(4-(R-amino)-1-pyridini discloses a group of bis-(4-amino-1-pyridinium)alkanes. umlalkane and a compatible, pharmaceutically accept No utility is disclosed for these compounds other than able carrier. as intermediates in the preparation of the corresponding In another composition aspect, the present invention bis-(4-amino-1-piperidino)alkanes which are stated to provides an antimicrobial composition suitable for ap have bacteriostatic and bactericidal effects. 30 plication to inanimate surfaces comprising an antimi G. N. Walker et al., J. Org. Chem. 26, 2740-7 (1961) crobially effective amount of a bis-(4-(R-amino)-1- disclose essentially the subject matter disclosed in the pyridiniumalkane in admixture with a compatible vehi above-noted Walker U.S. patent. cle. W. C. Austin et al., J. Pharm. Pharmacol. 11, 80-93 In a method aspect, the present invention provides a (1959) disclose 1,10-bis-(4-amino-1-pyridinium)decane 35 method for controlling microorganisms which com diiodide and 1,10-bis(4-acetamido-1-pyridinium)decane prises contacting said microorganisms with an antimi diiodide. It is stated that certain species among the crobially effective amount of a bis-(4-(R-amino)-1- large, diverse group of quaternary ammonium com pyridiniumalkane. pounds disclosed possess amebicidal, antibacterial, anti In a further method aspect, this invention is con filarial and trypanocidal activity, but no biological data 40 cerned with a method for treating teeth to prevent the are given for either of the above-named compounds. formation of dental plaque thereon which comprises Edwards U.S. Pat. No. 3,786,058, issued Jan. 15, 1974 contacting the teeth with an effective amount of a den discloses a group of bis(pyridinium quaternary salts) tal plaque-preventive bis-(4-(R-amino)-1-pyridinium al believed to be structurally more remote from the kane. claimed compounds than the above-noted Walker and 45 DETAILED DESCRIPTION INCLUSIVE OF THE Austin et al. compounds and having the formula PREFERRED EMBODIMENTS The invention sought to be patented resides in one of its composition aspects in the bis-(4-(R-amino)-1- pyridinium-alkanes having Formula I hereinbelow: SN n N +2 er eks: W 7 RNH / N-Yann \ NHR A * wherein inter alia: 55 R1 and R2 are alkyl of 6 to 14 carbon atoms; n A1 and A2 are a direct linkage; R R A3 is -NHCH2)NH-, m being 0 to 12; and wherein: X.X represents two monoanions or a dianion. It is Y is an alkkylene group containing from 4 to 18 car stated that the compounds possess antibacterial bon atoms and separating the two 4-(R-NH)-1- properties and that some are useful in dental hy pyridinyl groups by from 4 to 18 carbon atoms; giene for inhibiting the formation of dental plaque. R is an alkyl group containing from 6 to 18 carbon In the above compounds the pyridinium groups are atoms, a cycloalkyl group containing from 5 to 7 linked through an alkylene diamine chain bonded carbon atoms, benzyl, or phenyl substituted by to the carbon atoms of the pyridine rings and thus 65 methylenedioxy or one or two substituents selected constitute a class of compounds which are separate from the group consisting of halogen, lower-alkyl, and distinct from the instantly claimed bis lower-alkoxy, nitro, cyano and trifluoromethyl; (pyridinium)alkanes in which the pyridinium R1 is hydrogen or lower alkyl; 4,206,215 4. A is an anion; 1,10-Bis-(4-(2-ethylhexylamino)-1-pyridinium)-dec m is 1 or 3; ane dichloride, n is 1 or 2; 1,12-Bis-4-(hexylamino)-1-pyridiniumdodecane di x is 1, 2 or 3; and bromide and the corresponding dichloride, wherein (m)(2)=(n)(x). 1,12-Bis-(4-(heptylamino)-1-pyridiniumdodecane di These compounds are useful as antibacterial and anti bromide, fungal agents and are virucidally active against Herpes 1, 12-Bis-4-(octylamino)-1-pyridiniumdodecane di viruses. bromide, Included in the above group are the compounds hav 1,12-Bis-4-(nonylamino)-1-pyridiniumdodecane di ing Formula I wherein Y, A, R1, m, n and x have the 10 bromide, abovegiven meaning and wherein: 1,12-Bis-(4-(decylamino)-1-pyridiniumdodecane di (a) R is an alkyl group containing from 6 to 18 carbon bromide, atoms; 1,12-Bis-4-(dodecylamino)-1-pyridiniumdodecan (b) R is a cycloalkyl group containing from 5 to 7 dibromide, carbon atoms; 15 1,12-Bis-4-(2-ethylhexylamino)-1-pyridinium (c) R is phenyl substituted by methylenedioxy or one dodecane dibromide and the corresponding dichloride, or two substituents selected from the group consisting 1,14-Bis-4-(hexylamino)-1-pyridiniumtetradecane of halogen, lower-alkyl, lower-alkoxy, nitro, cyano and dibromide and the corresponding dichloride, trifluoromethyl; 1,14-Bis-4-(heptylamino)-1-pyridiniumtetradecane (d) R is benzyl. 20 dibromide and the corresponding dichloride, Certain of the compounds of Formula I are also use 1,14-Bis-4-(octylamino)-1-pyridinium tetradecane ful as dental plaque-preventive agents, for example: dibromide, 1,6-Bis-4-(octylamino)-1-pyridinium hexane dibro 1,10-Bis-(4-(octylamino)-1-pyridinium)decane bis(1- mide and the corresponding dichloride, oxo-2-pyridinethiolate), 1,6-Bis-4-(nonylamino)-1-pyridinium hexane dibro 25 mide and the corresponding dichloride, and, as particularly preferred species, 1,6-Bis-4-(decylamino)-1-pyridinium hexane dibro 1,9-Bis-(4-(heptylamino)-1-pyridiniumnonane dibro mide, mide, 1,6-Bis-4-(dodecylamino)-1-pyridinium hexane di 1,10-Bis-(4-(2-ethylhexylamino)-1-pyridinium-dec bromide, 30 ane dibromide, 1,7-Bis-(4-(heptylamino)-1-pyridinium heptane dibro 1,10-Bis-4-(octylamino)-1-pyridinium)decane dichlo mide, ride and the corresponding dibromide, 1,7-Bis-4-(octylamino)-1-pyridinium]heptane dibro 19-Bis-4-(octylamino)-1-pyridiniumnonane dibro mide, mide, 1,7-Bis-(4-(nonylamino)-1-pyridinium]heptane dibro 35 1,2-Bis-4-(heptylamino)-1-pyridiniumdodecane di mide, chloride, and 1,7-Bis-4-(decylamino)-1-pyridiniumheptane dibro 1,8-Bis-4-(octylamino)-1-pyridinium]octane dibro mide, mide. 1,7-Bis-4-(dodecylamino)-1-pyridinium]heptane di In a further composition aspect the invention sought bromide, to be patented resides in an antimicrobial composition 1,8-Bis-4-(heptylamino)-1-pyridinium]octane dibro suitable for topical administration which comprises an mide and the corresponding dichloride, effective amount of a compound having the Formula I 1,8-Bis-4-(octylamino)-1-pyridinium]octane dichlo hereinabove and a compatible, pharmaceutically ac ride, ceptable carrier.